A Provider of Wearable Drug Delivery Solutions
EOFlow Co., Ltd., a provider of wearable drug delivery solutions, announced on June 16 that it made a presentation on diabetes management and had business partnership meetings at the German-Korean Business Forum held at the Korea Advanced Institute of Science and Technology (KAIST) on June 15.
The forum was held by the Ministry of Science and ICT, KAIST, KAIST Global Commercialization Center (KAIST GCC), and German-Korean Business Forum (GKBF) at KAIST's main campus in Daejeon city. Research professors from KAIST and internationally renowned healthcare companies in Germany and Korea participated in the forum.
The forum was held to foster a Korean and German technology commercialization ecosystem. Topics such as digital health, non-invasive measurement methods of body parameters, and diabetes care were discussed.
EOFlow’s founder and CEO Jesse J. Kim spoke on “Digital Diabetes Management: Status & Trend,” where he delivered a presentation on EOFlow’s smart wearable drug delivery platform. After the forum, business meetings were held to encourage partnerships. EOFlow said that the company had fruitful meetings on various applications of wearable insulin pump technology.